Real-time enrollment status for this her2-negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:41 AM UTC
| NCT Number | NCT05029999 |
| Recruiting Status | Recruiting |
| Condition | HER2-negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 7 sites in the US |
| Sponsor | University of Texas Southwestern Medical Center |
| Last Updated on CT.gov | June 17, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT05029999 is currently recruiting participants. This clinical trial study for her2-negative breast cancer is actively seeking new participants at 7 locations across the United States. The study is sponsored by University of Texas Southwestern Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05029999 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05029999 was last updated 3 weeks ago (June 17, 2026). HelloStudys verifies this status automatically.